Developer docs
API playgroundTry for free, no card

Search company profiles

Planet Innovation

Full company profile

uuid000afug

Namestring
Planet Innovation
Legal namestring
Planet Innovation Pty Ltd
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Planet Innovation is a privately held healthtech innovation and contract development and manufacturing organization (CDMO) founded in 2009 in Melbourne, Australia, with a US headquarters in Irvine, California. The company provides end-to-end product development, commercialization, digital, and manufacturing services to enterprise clients across diagnostics, life sciences, and healthcare technology — spanning instrument design, electronics, software/firmware, optics, systems engineering, human factors, regulatory affairs, and FDA-registered manufacturing under ISO 13485:2016 and ISO 9001 certifications across approximately 100,000 sq. ft. of facilities including ISO 7 cleanrooms.

The company's revenue model blends professional services (fee-for-service design, engineering, regulatory, and commercialization engagements) with hardware sales from contract manufacturing of regulated medical instruments and consumables, plus digital services revenue from custom connected-health and IoT platforms. Pricing is bespoke and quote-based with multi-year contracts, and the GTM is enterprise field sales supported by dedicated product managers. Notable manufactured products include the Geri IVF Imaging Incubator and Gavi embryo-freezing instrument (Genea Biomedx), the ASP Health automated sample preparation platform, the Rotea counterflow centrifugation system (Scinogy/Gibco CTS), the Truvian TruVerus benchtop blood testing platform, the AVATAR Foundry solid-tumor cell therapy instrument (Xcell Biosciences), the SLIDEVIEW DX VS-M1 digital pathology scanner (Evident), the Dermapen 4 micro-needling device (DermapenWorld, 50,000+ units shipped to 100+ countries), and the Ramsay Health Care non-invasive patient monitoring system. Production capacity is demonstrated at 1,000 instruments per month for a single global diagnostics client.

Planet Innovation serves a concentrated base of enterprise healthtech clients including Abbott, Bio-Rad, Merck, IDEX Health & Science, Meridian Bioscience, Truvian, Genea Biomedx, and DermapenWorld, with over 90% repeat customer engagement. Recent strategic actions — the 2023 acquisition of BIT USA, the July 2025 Meiban Corp Holdings strategic alliance (with Meiban taking a ~20% equity stake to extend manufacturing into Asia), the February 2025 RANGER consortium partnership with Ginkgo Bioworks ($25.1M program), and the October 2025 Precision Cell Systems cell-analysis ecosystem partnership — position the company as a scaled, geographically distributed MedTech CDMO with growing regulatory and ecosystem leverage.

Short descriptiontext

Planet Innovation is a privately held healthtech CDMO offering end-to-end product design, engineering, digital, and FDA-registered manufacturing services to enterprise diagnostics, life sciences, and medical device companies across the US, Australia, and Asia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersBox Hill, Australia
HQ citystring
Box Hill
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device development, contract manufacturing services, healthtech product design, diagnostic instrument manufacturing, medical device commercialization
Industry2 codes
PRIMARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAD
Cell Therapy CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Medical Equipment and Supplies Manufacturing33911
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Healthtech Contract Development and Manufacturing (CDMO)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Development Services
TypeProfessional Services
Description

Fee-for-service product development engagements covering design, engineering, regulatory strategy, and commercialization support. PI provides personalized service with flexible engagement models that can scale up or down based on client needs.

planetinnovation.com
2Contract Manufacturing Services
TypeHardware Sales
Description

Manufacturing of regulated medical instruments and consumables ranging from low-complexity devices to large floor-standing IVD instruments. Revenue generated through production contracts with flexible supply and quality agreements.

planetinnovation.com
3Digital Services
TypeProfessional Services
Description

Customized digital health and IoT solutions for regulated medical environments, including platform development, managed operations, and launch management services.

planetinnovation.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Bespoke service engagements
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is tailored to individual client needs and project scope. PI offers flexible approach and ability to scale support, indicating custom quotation-based pricing rather than standardized tiers.

planetinnovation.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Planet Innovation is a healthtech-focused contract development and manufacturing organization (CDMO) that delivers end-to-end services spanning product development, commercialization, digital services, and regulated manufacturing for the diagnostics, life sciences, and healthcare industries. The company combines industrial design, mechanical/electronics/software engineering, regulatory strategy, and FDA-registered ISO 13485 manufacturing under one roof to take connected medical devices, IVD instruments, and digital health solutions from concept through commercial production.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 90% repeat customer engagement rate
+3 more records
Product overview1 text field

Planet Innovation is a healthtech innovation and contract development and manufacturing organization (CDMO) offering end-to-end services spanning product development, commercialization, digital services, and manufacturing for the diagnostics, life sciences, and healthcare industries. The company provides both as-a-service capabilities and manufactured products including connected healthcare instruments (Geri IVF Imaging Incubator, ASP Health sample preparation platform, Truvian blood testing platform), cell therapy manufacturing systems (Rotea, AVATAR Foundry), digital health solutions (QBOX IVF, Non-invasive Patient Monitoring System, Zen HQ), diagnostic platforms (Proof Lab Test System, VIP2000), and consumables. The portfolio includes products developed in partnership with clients such as Abbott, ASP Health, Genea Biomedx, Merck, Ramsay Health Care, Truvian, Xcell Biosciences, and Evident, with manufacturing capabilities spanning instruments and consumables across approximately 100,000 sq. ft. of FDA-registered facilities in Irvine, California and Melbourne, Australia.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

Unique partnership model where PI provides extensive product development capacity through its 300+ experts and access to global manufacturing facilities in USA, Australia and Singapore. PCS consolidates cell analysis technologies and supports them with common commercial and operational infrastructure, eliminating substantial overhead costs for emerging technology companies. PI scales manufacturing up as PCS achieves commercial traction.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-07-01
Description

Strategic alliance between PI and Meiban to deliver comprehensive CDMO services spanning from early-stage innovation through high-volume manufacturing. PI brings innovation, design, and early-stage manufacturing from Australia and USA; Meiban provides world-class automated mass manufacturing through 18 sites in Singapore and Malaysia with vertically integrated capabilities including plastic injection molding and PCB assembly. Meiban takes approximately 20% equity stake in Planet Innovation. This partnership creates one of the strongest offerings in the MedTech CDMO space.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-01-01
Description

Partnership for development and manufacturing of QSI's next generation protein sequencing instrument. PI brings product development and manufacturing expertise to support Quantum-Si's innovative benchtop next-gen protein sequencing instrument for clinical proteomics and pathogen detection.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

PI selected as key technology partner in USD $25.1 million RANGER consortium led by Ginkgo Bioworks to develop rapid, point-of-care, sequencing-based test for respiratory pathogens. The RANGER (Rapid Next-Generation Sequencing for Effective Medical Response) program aims to develop metagenomic sequencing solution with 6-hour turnaround time for hospitals and healthcare facilities.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-01-01
Description

Partner in RANGER consortium providing CRISPR-based technology for the Cipher system developed by PI. Jumpcode's technology enables comprehensive pathogen detection.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-01-01
Description

Partner in RANGER consortium providing clinically-tailored bioinformatics platform for rapid metagenomic sequencing for infectious disease diagnostics.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Partner in RANGER consortium contributing translational research expertise. TGen published findings with Jumpcode on initial version of the system being developed.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-01-01
Description

Medical device regulatory specialists collaborating with consortium to secure EU certification and validation for the RANGER device before market entry.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

PI developed and manufactured the AVATAR Foundry instrument - world-first technology that grows cell therapies under unique conditions to target solid tumor cancers. XcellBio was named finalist in International Design Excellence Awards 2025 for this instrument. In March 2025, XcellBio announced agreement with Royal Perth Hospital for trial focused on rapid manufacturing of more potent cancer-killing cell therapies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Partnership to develop and manufacture innovative digital workflow solutions for life science markets. Resulted in SLIDEVIEW DX VS-M1 scanner winning Design and Usability award at International Scanner Benchmark 2025.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

PI acquired BIT Group's North American operations (BIT USA) based in Irvine, California, adding 29,000 sq. ft. facility and doubling PI's medtech manufacturing capacity.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Cell analysis technology company acquired by PCS as part of the cell analysis ecosystem consolidation. PI provides manufacturing support through its partnership with PCS.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Cell analysis technology company acquired by PCS. PI provides manufacturing support through its partnership with PCS.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Cell analysis technology company acquired by PCS. PI provides manufacturing support through its partnership with PCS.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Full-service commercialization partnership with DermapenWorld. PI initially provided electronics and software services, then expanded to become manufacturing partner. PI has manufactured approximately 70,000 Dermapen microneedling devices shipped to over 100 countries worldwide. Product backed by 7-year warranty reflecting manufacturing reliability.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to improve patient safety in general wards through non-invasive patient monitoring system using sensors connected to real-time algorithmic decision support tools to detect early signs of patient deterioration and falls.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

PI developed and manufactured APAS Independence - standalone automated culture plate reading instrument that received MDEA Silver Award and multiple Good Design Awards.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Donatelle is a US-based medical device contract manufacturer offering design, prototyping, injection molding and assembly for Class I-III devices. Comparable to PI's US-based medical device manufacturing capability though smaller in scale and more focused on plastics-driven devices than diagnostics instruments.

TypeDirect peer
Description

Phillips-Medisize (a Molex company) is a global MedTech CDMO providing design, development and manufacturing of medical devices and drug delivery products. Direct peer to PI given overlapping regulated medical device CDMO capabilities across diagnostics, connected health and life sciences instruments.

TypeBroad incumbent
Description

Jabil's Healthcare division is one of the largest global medical device and diagnostics CDMOs, offering design, manufacturing and supply chain services to leading OEMs. Comparable to PI's enterprise CDMO model but at materially larger scale and broader geographic reach.

TypeBroad incumbent
Description

Flex operates a global Health Solutions business providing design, manufacturing and supply chain services for medical devices, diagnostics and connected health products. Overlaps PI's end-to-end MedTech CDMO offering but at much greater scale and broader industry exposure.

TypeBroad incumbent
Description

Sanmina provides integrated manufacturing solutions including medical device and diagnostics manufacturing, with FDA-registered facilities globally. Comparable to PI's regulated medical device manufacturing capability, though Sanmina operates at much larger scale across multiple end markets.

TypeDirect peer
Description

Resonetics is a medical device contract manufacturer specializing in diagnostic and interventional medical technologies with capabilities in nitinol, laser processing, and finished device assembly. Comparable niche medical device CDMO positioning to PI's diagnostics and connected health focus.

TypeDirect peer
Description

StarFish Medical is a Canadian medical device design and manufacturing services firm serving diagnostics and life science instrumentation companies. Closely comparable to PI's integrated design-through-manufacturing model for IVD and life sciences instruments.

TypeDirect peer
Description

Cambridge Consultants is a UK-based product development and engineering firm with deep medical and life sciences practice covering IVD, connected health and surgical devices. Comparable to PI on the innovation and product development services side of the CDMO value chain.

TypeDirect peer
Description

Meiban is a Singapore-headquartered precision contract manufacturer with 18 facilities across Singapore and Malaysia offering plastic injection molding, PCB assembly and full product assembly. Became PI's strategic alliance partner and ~20% shareholder in July 2025 to deliver end-to-end MedTech CDMO services, making it both partner and adjacent competitor.

TypeBroad incumbent
Description

Celestica's Healthcare & Life Sciences segment provides design, manufacturing and supply chain solutions for medical devices, diagnostics and connected health OEMs. Comparable regulated medical device CDMO services but operating at much greater global scale than PI.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Planet Innovation

Healthtech Contract Development and Manufacturing (CDMO)planetinnovation.com

Planet Innovation is a privately held healthtech CDMO offering end-to-end product design, engineering, digital, and FDA-registered manufacturing services to enterprise diagnostics, life sciences, and medical device companies across the US, Australia, and Asia.

What Planet Innovation does

Planet Innovation is a privately held healthtech innovation and contract development and manufacturing organization (CDMO) founded in 2009 in Melbourne, Australia, with a US headquarters in Irvine, California. The company provides end-to-end product development, commercialization, digital, and manufacturing services to enterprise clients across diagnostics, life sciences, and healthcare technology — spanning instrument design, electronics, software/firmware, optics, systems engineering, human factors, regulatory affairs, and FDA-registered manufacturing under ISO 13485:2016 and ISO 9001 certifications across approximately 100,000 sq. ft. of facilities including ISO 7 cleanrooms.

The company's revenue model blends professional services (fee-for-service design, engineering, regulatory, and commercialization engagements) with hardware sales from contract manufacturing of regulated medical instruments and consumables, plus digital services revenue from custom connected-health and IoT platforms. Pricing is bespoke and quote-based with multi-year contracts, and the GTM is enterprise field sales supported by dedicated product managers. Notable manufactured products include the Geri IVF Imaging Incubator and Gavi embryo-freezing instrument (Genea Biomedx), the ASP Health automated sample preparation platform, the Rotea counterflow centrifugation system (Scinogy/Gibco CTS), the Truvian TruVerus benchtop blood testing platform, the AVATAR Foundry solid-tumor cell therapy instrument (Xcell Biosciences), the SLIDEVIEW DX VS-M1 digital pathology scanner (Evident), the Dermapen 4 micro-needling device (DermapenWorld, 50,000+ units shipped to 100+ countries), and the Ramsay Health Care non-invasive patient monitoring system. Production capacity is demonstrated at 1,000 instruments per month for a single global diagnostics client.

Planet Innovation serves a concentrated base of enterprise healthtech clients including Abbott, Bio-Rad, Merck, IDEX Health & Science, Meridian Bioscience, Truvian, Genea Biomedx, and DermapenWorld, with over 90% repeat customer engagement. Recent strategic actions — the 2023 acquisition of BIT USA, the July 2025 Meiban Corp Holdings strategic alliance (with Meiban taking a ~20% equity stake to extend manufacturing into Asia), the February 2025 RANGER consortium partnership with Ginkgo Bioworks ($25.1M program), and the October 2025 Precision Cell Systems cell-analysis ecosystem partnership — position the company as a scaled, geographically distributed MedTech CDMO with growing regulatory and ecosystem leverage.

Planet Innovation firmographics

Firmographics
Name
Planet Innovation
Legal name
Planet Innovation Pty Ltd
Website
https://planetinnovation.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
251–500 employees
Short description
Planet Innovation is a privately held healthtech CDMO offering end-to-end product design, engineering, digital, and FDA-registered manufacturing services to enterprise diagnostics, life sciences, and medical device companies across the US, Australia, and Asia.
Ownership category
akta.pro rank

Planet Innovation industry classification

Industry
Product category
Healthtech Contract Development and Manufacturing (CDMO)
NAICS
Scientific Research and Development Services (5417), Medical Equipment and Supplies Manufacturing (33911), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAD
Cell Therapy CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Medical device development
  • Contract manufacturing services
  • Healthtech product design
  • Diagnostic instrument manufacturing
  • Medical device commercialization

Where Planet Innovation is headquartered

Location

Headquarters

HQ city
Box Hill
HQ country
Australia
HQ region
Oceania

Offices3 records

Markets served

Planet Innovation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Contract Development Services: Fee-for-service product development engagements covering design, engineering, regulatory strategy, and commercialization support. PI provides personalized service with flexible engagement models that can scale up or down based on client needs.
  2. Contract Manufacturing Services: Manufacturing of regulated medical instruments and consumables ranging from low-complexity devices to large floor-standing IVD instruments. Revenue generated through production contracts with flexible supply and quality agreements.
  3. Digital Services: Customized digital health and IoT solutions for regulated medical environments, including platform development, managed operations, and launch management services.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractBespoke service engagements

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Planet Innovation product offering

Product offering

Core offering

Planet Innovation is a healthtech-focused contract development and manufacturing organization (CDMO) that delivers end-to-end services spanning product development, commercialization, digital services, and regulated manufacturing for the diagnostics, life sciences, and healthcare industries. The company combines industrial design, mechanical/electronics/software engineering, regulatory strategy, and FDA-registered ISO 13485 manufacturing under one roof to take connected medical devices, IVD instruments, and digital health solutions from concept through commercial production.

Product overview

Planet Innovation is a healthtech innovation and contract development and manufacturing organization (CDMO) offering end-to-end services spanning product development, commercialization, digital services, and manufacturing for the diagnostics, life sciences, and healthcare industries. The company provides both as-a-service capabilities and manufactured products including connected healthcare instruments (Geri IVF Imaging Incubator, ASP Health sample preparation platform, Truvian blood testing platform), cell therapy manufacturing systems (Rotea, AVATAR Foundry), digital health solutions (QBOX IVF, Non-invasive Patient Monitoring System, Zen HQ), diagnostic platforms (Proof Lab Test System, VIP2000), and consumables. The portfolio includes products developed in partnership with clients such as Abbott, ASP Health, Genea Biomedx, Merck, Ramsay Health Care, Truvian, Xcell Biosciences, and Evident, with manufacturing capabilities spanning instruments and consumables across approximately 100,000 sq. ft. of FDA-registered facilities in Irvine, California and Melbourne, Australia.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Over 90% repeat customer engagement rate
  • +3 more outcomes

Companies that use Planet Innovation

Customer profile

Named customers14 records

Segments4 records

Ideal customer profiles4 records

Planet Innovation technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Planet Innovation partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core, flagship and minor.

  • Precision Cell Systems (PCS)coreStrategic or Co-development Partner · 1 October 2025Unique partnership model where PI provides extensive product development capacity through its 300+ experts and access to global manufacturing facilities in USA, Australia and Singapore. PCS consolidates cell analysis technologies and supports them with common commercial and operational infrastructure, eliminating substantial overhead costs for emerging technology companies. PI scales manufacturing up as PCS achieves commercial traction.
  • Meiban Corp HoldingsflagshipStrategic or Co-development Partner · 1 July 2025Strategic alliance between PI and Meiban to deliver comprehensive CDMO services spanning from early-stage innovation through high-volume manufacturing. PI brings innovation, design, and early-stage manufacturing from Australia and USA; Meiban provides world-class automated mass manufacturing through 18 sites in Singapore and Malaysia with vertically integrated capabilities including plastic injection molding and PCB assembly. Meiban takes approximately 20% equity stake in Planet Innovation. This partnership creates one of the strongest offerings in the MedTech CDMO space.
  • Quantum-SicoreTechnology or Integration · 1 January 2025Partnership for development and manufacturing of QSI's next generation protein sequencing instrument. PI brings product development and manufacturing expertise to support Quantum-Si's innovative benchtop next-gen protein sequencing instrument for clinical proteomics and pathogen detection.
  • Ginkgo BioworksflagshipStrategic or Co-development Partner · 1 January 2025PI selected as key technology partner in USD $25.1 million RANGER consortium led by Ginkgo Bioworks to develop rapid, point-of-care, sequencing-based test for respiratory pathogens. The RANGER (Rapid Next-Generation Sequencing for Effective Medical Response) program aims to develop metagenomic sequencing solution with 6-hour turnaround time for hospitals and healthcare facilities.
  • Jumpcode GenomicscoreTechnology or Integration · 1 January 2025Partner in RANGER consortium providing CRISPR-based technology for the Cipher system developed by PI. Jumpcode's technology enables comprehensive pathogen detection.
  • BugSeqcoreTechnology or Integration · 1 January 2025Partner in RANGER consortium providing clinically-tailored bioinformatics platform for rapid metagenomic sequencing for infectious disease diagnostics.
  • TGen (The Translational Genomics Research Institute) - Part of City of HopecoreStrategic or Co-development Partner · 1 January 2025Partner in RANGER consortium contributing translational research expertise. TGen published findings with Jumpcode on initial version of the system being developed.
  • QbD GroupminorImplementation/ SI/ Consulting Partner · 1 January 2025Medical device regulatory specialists collaborating with consortium to secure EU certification and validation for the RANGER device before market entry.
  • Xcell Biosciences (XcellBio)coreStrategic or Co-development Partner · 1 January 2023PI developed and manufactured the AVATAR Foundry instrument - world-first technology that grows cell therapies under unique conditions to target solid tumor cancers. XcellBio was named finalist in International Design Excellence Awards 2025 for this instrument. In March 2025, XcellBio announced agreement with Royal Perth Hospital for trial focused on rapid manufacturing of more potent cancer-killing cell therapies.
  • EvidentcoreStrategic or Co-development Partner · 1 January 2023Partnership to develop and manufacture innovative digital workflow solutions for life science markets. Resulted in SLIDEVIEW DX VS-M1 scanner winning Design and Usability award at International Scanner Benchmark 2025.
  • BIT GroupcoreStrategic or Co-development Partner · 1 January 2023PI acquired BIT Group's North American operations (BIT USA) based in Irvine, California, adding 29,000 sq. ft. facility and doubling PI's medtech manufacturing capacity.
  • S2 GenomicsminorStrategic or Co-development PartnerCell analysis technology company acquired by PCS as part of the cell analysis ecosystem consolidation. PI provides manufacturing support through its partnership with PCS.
  • ORFLOminorStrategic or Co-development PartnerCell analysis technology company acquired by PCS. PI provides manufacturing support through its partnership with PCS.
  • BennuBiominorStrategic or Co-development PartnerCell analysis technology company acquired by PCS. PI provides manufacturing support through its partnership with PCS.
  • DermapenWorldcoreStrategic or Co-development PartnerFull-service commercialization partnership with DermapenWorld. PI initially provided electronics and software services, then expanded to become manufacturing partner. PI has manufactured approximately 70,000 Dermapen microneedling devices shipped to over 100 countries worldwide. Product backed by 7-year warranty reflecting manufacturing reliability.
  • Ramsay Health CarecoreStrategic or Co-development PartnerPartnership to improve patient safety in general wards through non-invasive patient monitoring system using sensors connected to real-time algorithmic decision support tools to detect early signs of patient deterioration and falls.
  • Clever Culture SystemscoreStrategic or Co-development PartnerPI developed and manufactured APAS Independence - standalone automated culture plate reading instrument that received MDEA Silver Award and multiple Good Design Awards.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Planet Innovation competitors and assessment

Company assessment

Emerging players

  • Donatelle: Donatelle is a US-based medical device contract manufacturer offering design, prototyping, injection molding and assembly for Class I-III devices. Comparable to PI's US-based medical device manufacturing capability though smaller in scale and more focused on plastics-driven devices than diagnostics instruments.

Direct peers

  • Phillips-Medisize: Phillips-Medisize (a Molex company) is a global MedTech CDMO providing design, development and manufacturing of medical devices and drug delivery products. Direct peer to PI given overlapping regulated medical device CDMO capabilities across diagnostics, connected health and life sciences instruments.
  • Resonetics: Resonetics is a medical device contract manufacturer specializing in diagnostic and interventional medical technologies with capabilities in nitinol, laser processing, and finished device assembly. Comparable niche medical device CDMO positioning to PI's diagnostics and connected health focus.
  • StarFish Medical: StarFish Medical is a Canadian medical device design and manufacturing services firm serving diagnostics and life science instrumentation companies. Closely comparable to PI's integrated design-through-manufacturing model for IVD and life sciences instruments.
  • Cambridge Consultants: Cambridge Consultants is a UK-based product development and engineering firm with deep medical and life sciences practice covering IVD, connected health and surgical devices. Comparable to PI on the innovation and product development services side of the CDMO value chain.
  • Meiban Corp Holdings: Meiban is a Singapore-headquartered precision contract manufacturer with 18 facilities across Singapore and Malaysia offering plastic injection molding, PCB assembly and full product assembly. Became PI's strategic alliance partner and ~20% shareholder in July 2025 to deliver end-to-end MedTech CDMO services, making it both partner and adjacent competitor.

Broad incumbents

  • Jabil Healthcare: Jabil's Healthcare division is one of the largest global medical device and diagnostics CDMOs, offering design, manufacturing and supply chain services to leading OEMs. Comparable to PI's enterprise CDMO model but at materially larger scale and broader geographic reach.
  • Flex (Flextronics): Flex operates a global Health Solutions business providing design, manufacturing and supply chain services for medical devices, diagnostics and connected health products. Overlaps PI's end-to-end MedTech CDMO offering but at much greater scale and broader industry exposure.
  • Sanmina: Sanmina provides integrated manufacturing solutions including medical device and diagnostics manufacturing, with FDA-registered facilities globally. Comparable to PI's regulated medical device manufacturing capability, though Sanmina operates at much larger scale across multiple end markets.
  • Celestica: Celestica's Healthcare & Life Sciences segment provides design, manufacturing and supply chain solutions for medical devices, diagnostics and connected health OEMs. Comparable regulated medical device CDMO services but operating at much greater global scale than PI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Planet Innovation social profiles

Digital presence

Planet Innovation compliance and trust

Trust signal

Compliance11 records

Planet Innovation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Planet Innovation leadership team

Management profile

Number of profiles

Planet Innovation subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Planet Innovation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Planet Innovation M&A and investment

M&A and investment

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Planet Innovation

What does Planet Innovation do?

Planet Innovation is a healthtech-focused contract development and manufacturing organization (CDMO) that delivers end-to-end services spanning product development, commercialization, digital services, and regulated manufacturing for the diagnostics, life sciences, and healthcare industries. The company combines industrial design, mechanical/electronics/software engineering, regulatory strategy, and FDA-registered ISO 13485 manufacturing under one roof to take connected medical devices, IVD instruments, and digital health solutions from concept through commercial production.

Is Planet Innovation a public or private company?

Planet Innovation is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Planet Innovation founded?

Planet Innovation was founded in 2009. It employs 251 to 500 people.

Where is Planet Innovation based?

Planet Innovation is headquartered in Box Hill, Australia, in the Oceania region.

How does Planet Innovation make money?

Three revenue lines are on record. Contract Development Services are the primary driver. The others are contract Manufacturing Services and digital Services.

Who are Planet Innovation's main competitors?

Donatelle is listed as an emerging player. Direct peers are Phillips-Medisize, Resonetics, StarFish Medical, Cambridge Consultants and Meiban Corp Holdings. Broad incumbents are Jabil Healthcare, Flex (Flextronics), Sanmina and Celestica.

Does Planet Innovation have an API?

No public API is recorded for Planet Innovation.

What industry is Planet Innovation in?

Planet Innovation's product category is Healthtech Contract Development and Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAL, Process Development & Tech Transfer Services (CDMO), with a secondary code of HLAGABAD, Cell Therapy CDMO. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Manufacturers' MonthlyCompeting while staying cost-competitive in diagnostics manufacturingThe Australian Medtech Manufacturing Alliance highlights how three local manufacturers—SCHOTT MINIFAB, ZiP Diagnostics, and Planet Innovation—are competing globally in medical diagnostics production despite operating in higher-wage environments. The article demonstrates that cost competitiveness in advanced manufacturing is driven by how effectively companies combine automation, design-for-manufacture, and integrated production systems, rather than by labour costs or geographic location. These companies show that Australian medtech manufacturing is shifting toward a model where products and production systems are engineered together from the start, enabling them to compete internationally through CDMO structures.BiomelbournePlanet Innovation secures role in USD$25.1 million consortium advancing rapid mNGS respiratory diagnosticPlanet Innovation has been selected as a core technology partner in a USD$25.1 million international consortium aimed at developing a rapid, point-of-care sequencing test for respiratory pathogens. The project, led by Ginkgo Bioworks, includes collaboration with Jumpcode Genomics, BugSeq, TGen, and the European Health and Digital Executive Agency and is designed to deliver a device that can identify virtually any respiratory pathogen within six hours. The initiative is seen as a vital step in improving health system preparedness for both seasonal and emerging viral threats in the EU.YahooXcellbio Announces Partnership with Planet Innovation to Develop and Manufacture Next Generation Instruments to Improve potency for Rapid Cell Therapy ManufacturingXcellbio announced a partnership with Planet Innovation and Royal Perth Hospital to use its AVATAR Foundry platform for rapid manufacturing of potent cancer-killing cell therapies. The first clinical trial will begin at Royal Perth Hospital in mid-2025, with instruments shipped from Planet Innovation's facilities.Business Wire BlogQuantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst EventQuantum-Si announced Platinum Pro, a next-generation protein sequencing system launching in H1 2025, and Proteus, a new proteomics platform under development for H2 2026. Proteus aims to increase sequencing reads from tens of millions to billions per sample and enable de novo sequencing. The company also announced partnerships with Avantor, NVIDIA, SkyWater, and Planet Innovation.Stock TitanQuantum-Si Unveils Next-Gen Proteomic Platforms, Announces Major Tech PartnershipsQuantum-Si unveiled Platinum Pro, launching in H1 2025, and Proteus, a new proteomics platform, launching in H2 2026. The company announced partnerships with Avantor, NVIDIA, SkyWater, and Planet Innovation to support development and distribution. Proteus aims to increase sequencing reads to billions per sample and enable de novo sequencing.BovnewsWhat’s Behind Quantum-Si’s (QSI) 115% Stock Price Jump? – BOVNewsQuantum-Si's stock surged 114.84% to $1.36 in premarket trading after announcing partnerships with Avantor, NVIDIA, SkyWater, and Planet Innovation. The collaborations aim to expand distribution and accelerate its Proteus platform, expected to debut by mid-2025. The company's technology uses single-molecule sequencing for protein analysis.MorningstarQuantum-Si and Planet Innovation to Partner on Proteus™Quantum-Si and Planet Innovation announced a partnership to develop and manufacture Quantum-Si's Proteus proteomics platform. Planet Innovation, with over 400 people, will serve as contract manufacturer, aiming to deliver the instrument in under two years. The company's Platinum Pro instrument is set to debut in the first half of 2025.YahooQuantum-Si and Planet Innovation to Partner on Proteus™Quantum-Si and Planet Innovation announced a partnership to develop and manufacture Quantum-Si's Proteus proteomics platform. Planet Innovation, with over 400 people, will serve as contract manufacturer, aiming to deliver the instrument in under two years. The company's Platinum Pro instrument is set to debut in the first half of 2025.Stock TitanQuantum-Si Partners with Planet Innovation to Accelerate Proteus Platform DevelopmentQuantum-Si and Planet Innovation announced a partnership to develop and manufacture Quantum-Si's Proteus proteomics platform. Planet Innovation, with over 400 people, will serve as contract manufacturer, aiming to deliver the instrument in under two years. The company's Platinum Pro instrument is set to debut in the first half of 2025.Business Wire BlogQuantum-Si and Planet Innovation to Partner on Proteus ™Quantum-Si and Planet Innovation announced a partnership to develop and manufacture Quantum-Si's Proteus proteomics platform. Planet Innovation will serve as contract manufacturer, having already produced the Platinum Pro instrument. The company expects to deliver Proteus to market in under two years.